Spots Global Cancer Trial Database for Effect of Treatment Modality on Psychosocial Functioning of Survivors of Unilateral Retinoblastoma
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Effect of Treatment Modality on Psychosocial Functioning of Survivors of Unilateral Retinoblastoma
Official Title: Effect of Treatment Modality on Psychosocial Functioning of Survivors of Unilateral Retinoblastoma
Study ID: NCT03662776
Conditions
Study Description
Brief Summary: The purpose of this study is to find out about the quality of life and health in patients who had retinoblastoma in one eye (unilateral retinoblastoma), who either received treatment with chemotherapy injected directly into an artery leading to the eye (intra-arterial chemotherapy) or removal of the eye (enucleation). By quality of life, the investigators mean how the participants are feeling about being satisfied with things in their life, including, physical health, emotional health, and their ability to carry out daily activities. The investigators want to see if either treatment option would affect quality of life differently. The investigators hope that this information will help us provide better care to future children with retinoblastoma and better follow-up care for survivors of retinoblastoma.
Detailed Description:
Eligibility
Minimum Age: 8 Years
Eligible Ages: CHILD
Sex: ALL
Healthy Volunteers: No
Locations
Memorial Sloan Kettering Cancer Center, New York, New York, United States
Texas Children's Hospital (Data Collection), Houston, Texas, United States
Contact Details
Name: Laura Cimini, PhD
Affiliation: Memorial Sloan Kettering Cancer Center
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
